This episode also discusses clinical trial results from the latest COVID19 therapy Remdesivir, and the following question: “How can US GDP be down 30% and the stock market is only down 15%?”. Caller questions include, “Should I be buying stock ETFs during the COVID19 economy?,” and “When is it time to start using a financial advisor?”
This information is provided to you as a resource for educational purposes only and should not be considered investment advice or recommendation or an endorsement of any particular security. Investing involves risk, including the possible loss of principal. There is no guarantee offered that investment return, yield, or performance will be achieved. There will be periods of performance fluctuations, including periods of negative returns. Past performance is not indicative of future results when considering any investment vehicle. The mention of any specific security should not be inferred as having been successful or responsible for any client achieving their investment goals. Additionally, the mention of any specific security is not to infer investment success of the security or of any portfolio. Past performance is not indicative of future results. A reader may request a list of all recommendations made by Capital Investment Advisors within the immediately preceding period of one year upon written request to Capital Investment Advisors. It is not known whether any client holding the mentioned securities have achieved their investment goals or experienced appreciation of their portfolio. This information is being presented without consideration of the investment objectives, risk tolerance, or financial circumstances of any specific investor and might not be suitable for all investors. This information is not intended to, and should not, form a primary basis for any investment decision that you may make. Always consult your own legal, tax, or investment advisor before making any investment/tax/estate/financial planning considerations or decisions.